KR940005586B1 - 플라비 비루스 항원 - Google Patents
플라비 비루스 항원 Download PDFInfo
- Publication number
- KR940005586B1 KR940005586B1 KR1019860011649A KR860011649A KR940005586B1 KR 940005586 B1 KR940005586 B1 KR 940005586B1 KR 1019860011649 A KR1019860011649 A KR 1019860011649A KR 860011649 A KR860011649 A KR 860011649A KR 940005586 B1 KR940005586 B1 KR 940005586B1
- Authority
- KR
- South Korea
- Prior art keywords
- residue
- antigen
- amino acid
- acid sequence
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP131206 | 1986-06-05 | ||
| JP61131208A JPH0768267B2 (ja) | 1986-06-05 | 1986-06-05 | フラビウイルス抗原 |
| JP131208 | 1986-06-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR880000589A KR880000589A (ko) | 1988-03-28 |
| KR940005586B1 true KR940005586B1 (ko) | 1994-06-21 |
Family
ID=15052566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019860011649A Expired - Fee Related KR940005586B1 (ko) | 1986-06-05 | 1986-12-31 | 플라비 비루스 항원 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4810492A (https=) |
| JP (1) | JPH0768267B2 (https=) |
| KR (1) | KR940005586B1 (https=) |
| BE (1) | BE905815A (https=) |
| CA (1) | CA1270780A (https=) |
| DE (1) | DE3641040A1 (https=) |
| FR (1) | FR2599626B1 (https=) |
| GB (1) | GB2191201B (https=) |
| IT (1) | IT1198289B (https=) |
| NL (1) | NL189207C (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH084508B2 (ja) * | 1987-09-16 | 1996-01-24 | 国立予防衛生研究所長 | 組み換えワクチニアウイルス |
| JP2511494B2 (ja) * | 1988-05-12 | 1996-06-26 | 善治 松浦 | 日本脳炎ウイルス表面抗原蛋白質の製造法 |
| US6184024B1 (en) | 1988-07-14 | 2001-02-06 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric and/or growth-restricted flaviviruses |
| US6676936B1 (en) | 1988-07-14 | 2004-01-13 | The United States Of America As Represented By The Department Of Health And Human Services. | Chimeric and/or growth-restricted flaviviruses |
| FR2654113A1 (fr) * | 1989-11-09 | 1991-05-10 | Pasteur Institut | Procede de diagnostic de virus appartenant a la famille des flaviviridae. |
| SE470074B (sv) * | 1990-08-16 | 1993-11-01 | Replico Medical Ab | Förfarande för diagnos av picorna- och/eller flavivirusinfektion, peptider, diagnostiska antigener och vaccinkomposition med dessa peptider |
| US5494671A (en) * | 1990-08-27 | 1996-02-27 | The United States Of America As Represented By The Department Of Health And Human Services | C-terminally truncated dengue and Japanese encephalitis virus envelope proteins |
| US5824507A (en) * | 1994-05-20 | 1998-10-20 | Genelabs Technologies, Inc. | Hepatitis G virus and molecular cloning thereof |
| US5874563A (en) * | 1994-05-20 | 1999-02-23 | Genelabs Technologies, Inc. | Hepatitis G virus and molecular cloning thereof |
| DE69624815T2 (de) * | 1995-05-24 | 2003-07-10 | Hawaii Biotech Group | Untereinheitsimpfstoff gegen flavivirus infektion |
| US7227011B2 (en) * | 1998-06-04 | 2007-06-05 | United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Nucleic acid vaccines for prevention of flavivirus infection |
| IL139844A0 (en) | 1998-06-04 | 2002-02-10 | Us Gov Health & Human Serv | Nucleic acid vaccines for prevention of flavivirus infection |
| ATE526411T1 (de) * | 2000-02-16 | 2011-10-15 | Us Gov Health & Human Serv | Avirulente, immunogene flavivirus-chimäre |
| AU2003263853A1 (en) * | 2002-08-16 | 2004-03-03 | Board Of Regents The University Of Texas System | Compositions and methods related to flavivirus envelope protein domain iii antigens |
| JP5250179B2 (ja) * | 2002-11-08 | 2013-07-31 | ザ アドミニストレイターズ オブ ザ テューレイン エデュケイショナル ファンド | フラビウイルス融合インヒビター |
| CA3150411C (en) | 2009-07-31 | 2023-09-12 | Pnuvax Inc. | High yield yellow fever virus strain with increased propagation in cells |
| EP2968516B1 (en) | 2013-03-15 | 2022-01-12 | Takeda Vaccines, Inc. | Compositions and methods for dengue virus chimeric constructs in vaccines |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR76274B (https=) * | 1981-08-04 | 1984-08-04 | Univ California | |
| JPH0789951B2 (ja) * | 1986-06-18 | 1995-10-04 | 財団法人阪大微生物病研究会 | 遺伝子発現産物の精製法 |
| WO1988003032A1 (en) * | 1986-10-27 | 1988-05-05 | Fournier Maurielle J | Diagnosis of and vaccine for japanese encephalitis virus and related viruses |
-
1986
- 1986-06-05 JP JP61131208A patent/JPH0768267B2/ja not_active Expired - Lifetime
- 1986-11-14 CA CA000523040A patent/CA1270780A/en not_active Expired - Lifetime
- 1986-11-19 US US06/932,419 patent/US4810492A/en not_active Expired - Lifetime
- 1986-11-24 GB GB8628072A patent/GB2191201B/en not_active Expired - Lifetime
- 1986-11-26 FR FR868616491A patent/FR2599626B1/fr not_active Expired - Lifetime
- 1986-11-26 BE BE2/61092A patent/BE905815A/nl not_active IP Right Cessation
- 1986-11-27 NL NLAANVRAGE8603017,A patent/NL189207C/xx not_active IP Right Cessation
- 1986-11-28 IT IT22505/86A patent/IT1198289B/it active
- 1986-12-01 DE DE19863641040 patent/DE3641040A1/de active Granted
- 1986-12-31 KR KR1019860011649A patent/KR940005586B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0768267B2 (ja) | 1995-07-26 |
| JPS62286930A (ja) | 1987-12-12 |
| BE905815A (nl) | 1987-03-16 |
| GB8628072D0 (en) | 1986-12-31 |
| NL8603017A (nl) | 1988-01-04 |
| NL189207C (nl) | 1993-02-01 |
| DE3641040C2 (https=) | 1989-10-26 |
| GB2191201B (en) | 1991-01-23 |
| GB2191201A (en) | 1987-12-09 |
| FR2599626B1 (fr) | 1992-02-28 |
| IT1198289B (it) | 1988-12-21 |
| IT8622505A0 (it) | 1986-11-28 |
| US4810492A (en) | 1989-03-07 |
| KR880000589A (ko) | 1988-03-28 |
| FR2599626A1 (fr) | 1987-12-11 |
| DE3641040A1 (de) | 1987-12-10 |
| NL189207B (nl) | 1992-09-01 |
| CA1270780A (en) | 1990-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR940005586B1 (ko) | 플라비 비루스 항원 | |
| Löwenadler et al. | A gene fusion system for generating antibodies against short peptides | |
| Haynes et al. | Development of a genetically–engineered, candidate polio vaccine employing the self–assembling properties of the tobacco mosaic virus coat protein | |
| JP2661044B2 (ja) | 肝炎δの診断薬およびワクチン | |
| KR100217483B1 (ko) | C형 간염 바이러스 에피토프 | |
| JP2543751B2 (ja) | 抗原性蛋白質の製法 | |
| US5470720A (en) | HIV antibody assays comprising p24-gp41 chimeric antigens | |
| NL9002779A (nl) | Viraal middel. | |
| KR0178399B1 (ko) | 장을 통해 전염되는 비a비b형 간염 바이러스 병원체 및 그것의 특유한 에피토프 | |
| JPH08504096A (ja) | E型肝炎パキスタン株の組換えタンパク質ならびに診断法およびワクチンにおけるそれらの利用 | |
| Winther et al. | Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals. | |
| Goto et al. | Expression of the nucleoprotein of rabies virus in Escherichia coli and mapping of antigenic sites | |
| WO2025241210A9 (zh) | RSV pre-F突变体及其生产方法和用途 | |
| KR960005181B1 (ko) | 재조합 htlv-ⅲ 단백질 및 이의 용도 | |
| US5061623A (en) | Peptides comprising an immunogenic site of poliovirus and dnas containing nucleotide sequences coding for these peptides | |
| EP1042467B1 (en) | Non-identical genes and their application in improved molecular adjuvants | |
| JP2598596B2 (ja) | C型肝炎ウイルスの蛋白質に由来するポリペプチド、該ポリペプチドを含有するテストキットおよびc型肝炎ウイルス感染予防ワクチン | |
| JP3135060B2 (ja) | ヘモフィルスインフルエンザb型菌の外皮膜タンパク質P2の部分断片を用いた接合体 | |
| EP0154587B1 (en) | Fragments of dna which encode peptides capable of inducing in vivo the synthesis of anti-hepatitis a virus antibodies | |
| US5486473A (en) | A DNA coding for a Flavivirus antigen | |
| US5693497A (en) | Process for expressing the hepatitis B virus antigen using a Saccharomyces cerevisiae transformant | |
| JPH07265093A (ja) | 哺乳動物細胞を用いる日本脳炎ウイルス表面抗原蛋白質の製法 | |
| EP0343132A2 (en) | Methods and systems for producing HIV antigens | |
| KR0178110B1 (ko) | 대장균에서 발현된 인간유래 한탄바이러스의 뉴클레오캡시드 단백질을 이용한 백신 | |
| US5198536A (en) | Peptides comprising an immunogenic site of poliovirus and DNAs containing nucleotide sequences coding for these peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| G160 | Decision to publish patent application | ||
| PG1605 | Publication of application before grant of patent |
St.27 status event code: A-2-2-Q10-Q13-nap-PG1605 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 7 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 8 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 9 |
|
| FPAY | Annual fee payment |
Payment date: 20030211 Year of fee payment: 10 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 10 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20040622 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20040622 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-4-4-P10-P22-nap-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-4-4-P10-P22-nap-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-4-4-P10-P22-nap-X000 |